Skip to main content
Erschienen in: Pathology & Oncology Research 4/2019

19.11.2018 | Short Communication

CIZ1 Expression Is Upregulated in Hemangioma of the Tongue

verfasst von: Yue Wang, Xiaorui Li, Jiahao Zhang, Qiang Liu, Peng Gao, Di Li, Shijie Zhang, Ju Liu

Erschienen in: Pathology & Oncology Research | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Hemangioma is a vascular neoplasm and one of the most common benign tumors. The pathogenesis of hemangioma has not been fully understood. CIZ1 (Cip1-interacting zinc finger protein 1) is a nuclear protein and the binding partner of p21. Dysregulation of CIZ1 expression has been reported in various types of cancerous tissues. In this study, we examined CIZ1 expression in hemangioma of the tongue and explored its function in vascular endothelial cells, the proliferative cell type in hemangioma. Immunohistochemistry showed that CIZ1 was highly expressed in hemangioma of the tongue while its expression is minimal in the normal tongue tissues. In vitro, knockdown of CIZ1 expression by shRNA transfection significantly reduced the proliferation and migration of human umbilical vein endothelium cells (HUVECs), suggesting a positive role of CIZ1 in endothelial cell proliferation and migration. Therefore, CIZ1 might involve in pathogenesis of hemangioma of the tongue by regulation of endothelial cell functions.
Literatur
1.
Zurück zum Zitat Corrêa PH, Nunes LC, Johann AC, Aguiar MC, Gomez RS, Mesquita RA (2007) Prevalence of oral hemangioma, vascular malformation and varix in a Brazilian population. Braz Oral Res 21(1):40–45CrossRef Corrêa PH, Nunes LC, Johann AC, Aguiar MC, Gomez RS, Mesquita RA (2007) Prevalence of oral hemangioma, vascular malformation and varix in a Brazilian population. Braz Oral Res 21(1):40–45CrossRef
2.
Zurück zum Zitat Pranitha V, Puppala N, Deshmukh SN, Jagadesh B, Anuradha S (2014) Cavernous hemangioma of tongue: management of two cases. J Clin Diagn Res 8(10):ZD15–ZD17 Pranitha V, Puppala N, Deshmukh SN, Jagadesh B, Anuradha S (2014) Cavernous hemangioma of tongue: management of two cases. J Clin Diagn Res 8(10):ZD15–ZD17
3.
Zurück zum Zitat El-Raggal NM, El-Farrash RA, Saad AA, Attia EAS, Saafan HA, Shaaban IS (2018) Circulating levels of vascular endothelial growth factor and basic fibroblastic growth factor in infantile hemangioma versus vascular malformations. Clin Appl Thromb Hemost 24(4):663–668CrossRef El-Raggal NM, El-Farrash RA, Saad AA, Attia EAS, Saafan HA, Shaaban IS (2018) Circulating levels of vascular endothelial growth factor and basic fibroblastic growth factor in infantile hemangioma versus vascular malformations. Clin Appl Thromb Hemost 24(4):663–668CrossRef
4.
Zurück zum Zitat El-Hashemite N, Walker V, Kwiatkowski DJ (2005) Estrogen enhances whereas tamoxifen retards development of Tsc mouse liver hemangioma: a tumor related to renal Angiomyolipoma and pulmonary lymphangioleiomyomatosis. Cancer Res 65(6):2474–2481CrossRef El-Hashemite N, Walker V, Kwiatkowski DJ (2005) Estrogen enhances whereas tamoxifen retards development of Tsc mouse liver hemangioma: a tumor related to renal Angiomyolipoma and pulmonary lymphangioleiomyomatosis. Cancer Res 65(6):2474–2481CrossRef
5.
Zurück zum Zitat Liu Q, Niu N, Wada Y, Liu J (2016) The role of Cdkn1A-interacting zinc finger protein 1 (CIZ1) in DNA replication and pathophysiology. Int J Mol Sci 17(2):212CrossRef Liu Q, Niu N, Wada Y, Liu J (2016) The role of Cdkn1A-interacting zinc finger protein 1 (CIZ1) in DNA replication and pathophysiology. Int J Mol Sci 17(2):212CrossRef
6.
Zurück zum Zitat Wang DQ, Wang K, Yan DW, Liu J, Wang B, Li MX, Wang XW, Liu J, Peng ZH, Li GX, Yu ZH (2014) Ciz1 is a novel predictor of survival in human colon cancer. Exp Biol Med (Maywood) 239(7):862–870CrossRef Wang DQ, Wang K, Yan DW, Liu J, Wang B, Li MX, Wang XW, Liu J, Peng ZH, Li GX, Yu ZH (2014) Ciz1 is a novel predictor of survival in human colon cancer. Exp Biol Med (Maywood) 239(7):862–870CrossRef
7.
Zurück zum Zitat Zhou X, Liu Q, Wada Y, Liao L, Liu J (2017) CDKN1Ainteracting zinc finger protein 1 is a novel biomarker for lung squamous cell carcinoma. Oncol Lett 5(1):183–188 Zhou X, Liu Q, Wada Y, Liao L, Liu J (2017) CDKN1Ainteracting zinc finger protein 1 is a novel biomarker for lung squamous cell carcinoma. Oncol Lett 5(1):183–188
8.
Zurück zum Zitat Zhang D, Wang Y, Dai Y, Wang J, Suo T, Pan H, Liu H, Shen S, Liu H (2015) CIZ1 promoted the growth and migration of gallbladder cancer cells. Tumour Biol 36(4):2583–2591CrossRef Zhang D, Wang Y, Dai Y, Wang J, Suo T, Pan H, Liu H, Shen S, Liu H (2015) CIZ1 promoted the growth and migration of gallbladder cancer cells. Tumour Biol 36(4):2583–2591CrossRef
9.
Zurück zum Zitat Reggiani Bonetti L, Boselli F, Lupi M, Bettelli S, Schirosi L, Bigiani N, Sartori G, Rivasi F (2009) Expression of estrogen receptor in hemangioma of the uterine cervix: reports of three cases and review of the literature. Arch Gynecol Obstet 280(3):469–472CrossRef Reggiani Bonetti L, Boselli F, Lupi M, Bettelli S, Schirosi L, Bigiani N, Sartori G, Rivasi F (2009) Expression of estrogen receptor in hemangioma of the uterine cervix: reports of three cases and review of the literature. Arch Gynecol Obstet 280(3):469–472CrossRef
10.
Zurück zum Zitat den Hollander P, Rayala SK, Coverley D, Kumar R (2006) Ciz1, a novel DNA-binding coactivator of the estrogen receptor alpha, confers hypersensitivity to estrogen action. Cancer Res 66(22):11021–11029CrossRef den Hollander P, Rayala SK, Coverley D, Kumar R (2006) Ciz1, a novel DNA-binding coactivator of the estrogen receptor alpha, confers hypersensitivity to estrogen action. Cancer Res 66(22):11021–11029CrossRef
11.
Zurück zum Zitat Mai HM, Zheng JW, Wang YA, Yang XJ, Zhou Q, Qin ZP, Li KL (2013) CD133 selected stem cells from proliferating infantile hemangioma and establishment of an in vivo mice model of hemangioma. Chin Med J 126(1):88–94PubMed Mai HM, Zheng JW, Wang YA, Yang XJ, Zhou Q, Qin ZP, Li KL (2013) CD133 selected stem cells from proliferating infantile hemangioma and establishment of an in vivo mice model of hemangioma. Chin Med J 126(1):88–94PubMed
12.
Zurück zum Zitat Yu Y, Varughese J, Brown LF, Mulliken JB, Bischoff J (2001) Increased Tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells. Am J Pathol 159(6):2271–2280CrossRef Yu Y, Varughese J, Brown LF, Mulliken JB, Bischoff J (2001) Increased Tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells. Am J Pathol 159(6):2271–2280CrossRef
13.
Zurück zum Zitat Ou JM, Yu ZY, Qiu MK, Dai YX, Dong Q, Shen J, Wang XF, Liu YB, Quan ZW, Fei ZW (2014) Knockdown of VEGFR2 inhibits proliferation and induces apoptosis in hemangioma-derived endothelial cells. Eur J Histochem 58(1):2263CrossRef Ou JM, Yu ZY, Qiu MK, Dai YX, Dong Q, Shen J, Wang XF, Liu YB, Quan ZW, Fei ZW (2014) Knockdown of VEGFR2 inhibits proliferation and induces apoptosis in hemangioma-derived endothelial cells. Eur J Histochem 58(1):2263CrossRef
14.
Zurück zum Zitat Wu JK, Adepoju O, de Silva D, Baribault K, Boscolo E, Bischoff J, Kitajewski J (2010) A switch in notch gene expression parallels stem cell to endothelial transition in infantile hemangioma. Angiogenesis 13(1):15–23CrossRef Wu JK, Adepoju O, de Silva D, Baribault K, Boscolo E, Bischoff J, Kitajewski J (2010) A switch in notch gene expression parallels stem cell to endothelial transition in infantile hemangioma. Angiogenesis 13(1):15–23CrossRef
15.
Zurück zum Zitat Ji Y, Chen S, Li K, Li L, Xu C, Xiang B (2014) Signaling pathways in the development of infantile hemangioma. J Hematol Oncol 7:13CrossRef Ji Y, Chen S, Li K, Li L, Xu C, Xiang B (2014) Signaling pathways in the development of infantile hemangioma. J Hematol Oncol 7:13CrossRef
Metadaten
Titel
CIZ1 Expression Is Upregulated in Hemangioma of the Tongue
verfasst von
Yue Wang
Xiaorui Li
Jiahao Zhang
Qiang Liu
Peng Gao
Di Li
Shijie Zhang
Ju Liu
Publikationsdatum
19.11.2018
Verlag
Springer Netherlands
Erschienen in
Pathology & Oncology Research / Ausgabe 4/2019
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-018-0495-4

Weitere Artikel der Ausgabe 4/2019

Pathology & Oncology Research 4/2019 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.